Charlene Rico
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
Journal: Veterinary and comparative oncology
Published: December 12, 2022
Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells.
Journal: Veterinary and comparative oncology
Published: September 26, 2021
Lats1 and Lats2 are required for the maintenance of multipotency in the Müllerian duct mesenchyme.
Journal: Development (Cambridge, England)
Published: May 14, 2019
SFRP4 Is a Negative Regulator of Ovarian Follicle Development and Female Fertility.
Journal: Endocrinology
Published: March 15, 2019
Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Journal: Veterinary and comparative oncology
Published: April 25, 2018
In vitro efficacy of a first-generation valosin-containing protein inhibitor (CB-5083) against canine lymphoma.
Journal: Veterinary and comparative oncology
Published: August 28, 2017
In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Journal: Journal of mammary gland biology and neoplasia
Published: March 09, 2017
β-catenin stabilization in gonadotropes impairs FSH synthesis in male mice in vivo.
Journal: Endocrinology
Published: October 25, 2014
HIF1 activity in granulosa cells is required for FSH-regulated Vegfa expression and follicle survival in mice.
Journal: Biology of reproduction
Published: May 24, 2014
Effects of bone morphogenetic protein 4 (BMP4) supplementation during culture of the sheep ovarian cortex.
Journal: Animal reproduction science
Published: January 28, 2014
Regulation of anti-Müllerian hormone production in domestic animals.
Journal: Reproduction, fertility, and development
Published: December 19, 2012
Last Updated: 09/26/2026